LakeShore Biopharma Co. L... (LSB)
1.57
-0.19 (-10.80%)
At close: Apr 15, 2025, 3:59 PM
1.58
0.92%
After-hours: Apr 15, 2025, 05:25 PM EDT
-10.80% (1D)
| Bid | 1.45 |
| Market Cap | 29.96M |
| Revenue (ttm) | 577.33M |
| Net Income (ttm) | -436.09M |
| EPS (ttm) | -2.8 |
| PE Ratio (ttm) | -0.56 |
| Forward PE | -11.24 |
| Analyst | n/a |
| Ask | 1.95 |
| Volume | 38,819 |
| Avg. Volume (20D) | 14,837 |
| Open | 1.79 |
| Previous Close | 1.76 |
| Day's Range | 1.52 - 1.79 |
| 52-Week Range | 1.50 - 11.20 |
| Beta | 0.59 |
About LSB
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the Uni...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 5, 2021
Employees 758
Stock Exchange NASDAQ
Ticker Symbol LSB
Website https://www.ysbiopharm.com
6 months ago
+21.15%
LakeShore Biopharma shares are trading higher afte...
Unlock content with
Pro Subscription
8 months ago
+2.5%
LakeShore Biopharma shares are trading higher. The company reported FY24 financial results.
